FDA Inspection 542731 — Encore Pharmaceutical Inc.

Encore Pharmaceutical Inc. — FEI 2000046949

The FDA completed an inspection of Encore Pharmaceutical Inc. on Oct 20, 2008 in S Plainfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 20, 2008
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
S Plainfield, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.